Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 27, 2025
Particulate contamination in parenteral fluid from glass ampoules: compliance assessment and comparative analysis of needle types and ampoule-breaking strategies
Roland B van den Berg, Elizabeth Serbée-Wijker, Elsbeth M Westerman, et al.
Cancer Chemotherapy and Pharmacology
|
November 27, 2002
Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518
Mirjam Crul, Laurens V Beerepoot, Ellen Stokvis, et al.
Anti-Cancer Drugs
|
September 16, 2005
Phase I clinical and pharmacologic study of a 2-weekly administration of cisplatin and gemcitabine in patients with advanced non-small cell lung cancer
Jeany M Rademaker-Lakhai, Mirjam Crul, Dick Pluim, et al.
Biochemical Pharmacology
|
December 31, 2002
DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin
Mirjam Crul, Robert C A M van Waardenburg, Suzanne Bocxe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2006
Relationship between cisplatin administration and the development of ototoxicity
Jeany M Rademaker-Lakhai, Mirjam Crul, Lot Zuur, et al.
British Journal of Clinical Pharmacology
|
December 23, 2025
Model-informed precision dosing of carboplatin in cancer patients by leveraging myelosuppression data from electronic health records
Alessandro De Carlo, Elena Maria Tosca, Mirjam Crul, et al.
Cancer Chemotherapy and Pharmacology
|
March 27, 2002
Population pharmacokinetics of the novel anticancer agent KRN7000
Mirjam Crul, Ron A Mathôt, Giuseppe Giaccone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer
Mirjam Crul, Nadja E Schoemaker, Dick Pluim, et al.
Journal of Occupational and Environmental Medicine
|
April 17, 2025
Occupational Exposure of Healthcare Workers during Drug Reconstitution and Handling Tasks: a multicenter assessment at Dutch Hospital Wards
Roland B van den Berg, Percival Stubbs, Johanna R C Boumans-d'Onofrio, et al.
Oral Oncology
|
April 15, 2025
Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation
Anouk V M Burger, Melissa A Koot, Dorieke E M van Balen, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 27, 2025
Particulate contamination in parenteral fluid from glass ampoules: compliance assessment and comparative analysis of needle types and ampoule-breaking strategies
Roland B van den Berg, Elizabeth Serbée-Wijker, Elsbeth M Westerman, et al.
Cancer Chemotherapy and Pharmacology
|
November 27, 2002
Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518
Mirjam Crul, Laurens V Beerepoot, Ellen Stokvis, et al.
Anti-Cancer Drugs
|
September 16, 2005
Phase I clinical and pharmacologic study of a 2-weekly administration of cisplatin and gemcitabine in patients with advanced non-small cell lung cancer
Jeany M Rademaker-Lakhai, Mirjam Crul, Dick Pluim, et al.
Biochemical Pharmacology
|
December 31, 2002
DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin
Mirjam Crul, Robert C A M van Waardenburg, Suzanne Bocxe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2006
Relationship between cisplatin administration and the development of ototoxicity
Jeany M Rademaker-Lakhai, Mirjam Crul, Lot Zuur, et al.
British Journal of Clinical Pharmacology
|
December 23, 2025
Model-informed precision dosing of carboplatin in cancer patients by leveraging myelosuppression data from electronic health records
Alessandro De Carlo, Elena Maria Tosca, Mirjam Crul, et al.
Cancer Chemotherapy and Pharmacology
|
March 27, 2002
Population pharmacokinetics of the novel anticancer agent KRN7000
Mirjam Crul, Ron A Mathôt, Giuseppe Giaccone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer
Mirjam Crul, Nadja E Schoemaker, Dick Pluim, et al.
Journal of Occupational and Environmental Medicine
|
April 17, 2025
Occupational Exposure of Healthcare Workers during Drug Reconstitution and Handling Tasks: a multicenter assessment at Dutch Hospital Wards
Roland B van den Berg, Percival Stubbs, Johanna R C Boumans-d'Onofrio, et al.
Oral Oncology
|
April 15, 2025
Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation
Anouk V M Burger, Melissa A Koot, Dorieke E M van Balen, et al.
Page
of 6